Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study
Lesokhin, A. M., Ansell, S. M., Armand, P., Scott, E. C., Halwani, A., Gutierrez, M., Millenson, M. M., Cohen, A. D., Schuster, S. J., Lebovic, D., Dhodapkar, M., Avigan, D., Chapuy, B., Ligon, A. H.,Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2015.65.9789
Date:
June, 2016
File:
PDF, 972 KB
english, 2016